About Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome
Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome is a rare disease catalogued by Orphanet (ORPHA:313846). It is associated with the ATR gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome trials.
Search ClinicalTrials.gov for "Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome" or filter by Orphanet code ORPHA:313846 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome. Updated daily.